More on CRDL
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $1.76 |
|
|||
| Open | $1.75 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $1.77 | ||||
| Day Low | $1.69 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 55,375 | ||||
- H.C. Wainwright Starts Cardiol Therapeutics (CRDL) at Buy
- Form 6-K Cardiol Therapeutics For: Apr 02
- Cardiol Therapeutics (CRDL) Issues FY23 Operations Update
- Cardiol Therapeutics Announces Year-End 2023 Update on Operations
- Form 20-F Cardiol Therapeutics For: Dec 31
- Form 6-K Cardiol Therapeutics For: Feb 26
- Cardiol Therapeutics (CRDL) completes enrollment in its Phase II open-label pilot study of CardiolRx
- Form 6-K Cardiol Therapeutics For: Feb 21
- Cardiol Therapeutics Completes Patient Enrollment in its Phase II MAvERIC-Pilot Study Investigating CardiolRx(TM) for Recurrent Pericarditis
- Form 6-K Cardiol Therapeutics For: Feb 15
Entities mentioned with CRDL
- FDA | View Related Stories »
- F1 | View Related Stories »
- 13G | View Related Stories »
- Cantor Fitzgerald | View Related Stories »
- Canaccord Genuity | View Related Stories »
- Definitive Agreement | View Related Stories »
- IPO | View Related Stories »
- Deutsche Bank | View Related Stories »
- Show More...
